Did you mean: Pink v. Page et al ?
Web Results


Page 1 ... acute kidney injury with the new functional biomarker proenkephalin ( PENK). PENK is a stable surrogate marker for enkephalins ..... et al. (2017). Sepsis. (167). PENK vs. NGAL in detecting. AKI. (diagnosed with. KDIGO), compared.


Dec 4, 2015 ... (b) Penk mRNA expression was not altered in Nav1.8 KOs compared with littermates (female ..... How to cite this article: Minett, M. S. et al.


Nov 14, 2016 ... Because PDYN and PENK are expressed in dopamine D1- and D2-containing .... 12 (Slc39a12) in the NAc of shock resistant versus shock-sensitive rats (Fig. .... used to cause stress in the studies by Lang et al. and Schindler et al. ...... Journals A-Z · Subject Pages · Protocol Exchange · Blogs · Podcasts ...


Page SJ(1), Sisto S, Levine P, McGrath RE. Author information: (1)Department of Physical Medicine and Rehabilitation, University of Cincinatti College of ...


Page 1 ... mitted wild-type (WT) and PENK KO male mice to chronic ... preproenkephalin (Penk) gene (Konig et al. ..... vs. novel stressors (Dedovic et al. 2009 ...


Jan 3, 2010 ... Page 1 ... the Journal by Ng et al. (2) reporting the predictive role of proenkephalin (PENK) for outcome and devel- opment of renal dysfunction in heart failure ... chronic; primary causal mechanism being cardiac vs. renal vs.


Volume 135, Issue 2, February 2015, Pages 333-334 ... In agreement with this concept, expression of PENK and PENK-derived neuropeptides is ... In addition, the proposed role of DORs in wound healing (Neumann et al., 2014) would require .... v, vii. Slominski et al., 2011. A.T. Slominski, M.A. Zmijewski, B. Zbytek, et al.


Jan 19, 2018 ... Page 1 ... PITX1 [13–15]. Pdyn and Penk are also predominantly expressed in the brain. In addition, all endogenous opioids are ..... Yuferov V, Nielsen DA, Levran O, Randesi M, Hamon S, Ho A, et al. Tissue-specific DNA ...


Apr 9, 2018 ... Page 1 ... the Penk gene are upregulated in Nav1.7 nulls (3). ..... 3) Minett MS, Pereira V, Sikandar S, Matsuyama A, Lolignier S, Kanellopoulos AH, .... and DOR null mutants (Filliol et al., 2000; Matthes et al., 1996) were used.